Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Mais filtros

Bases de dados
Ano de publicação
Tipo de documento
Assunto da revista
País de afiliação
Intervalo de ano de publicação
1.
Biomacromolecules ; 18(2): 363-373, 2017 02 13.
Artigo em Inglês | MEDLINE | ID: mdl-28026947

RESUMO

Kojic acid (KA) is a naturally occurring fungal metabolite that is utilized as a skin-lightener and antibrowning agent owing to its potent tyrosinase inhibition activity. While efficacious, KA's inclination to undergo pH-mediated, thermal-, and photodegradation reduces its efficacy, necessitating stabilizing vehicles. To minimize degradation, poly(carbonate-esters) and polyesters comprised of KA and natural diacids were prepared via solution polymerization methods. In vitro hydrolytic degradation analyses revealed KA release was drastically influenced by polymer backbone composition (e.g., poly(carbonate-ester) vs polyester), linker molecule (aliphatic vs heteroatom-containing), and release conditions (physiological vs skin). Tyrosinase inhibition assays demonstrated that aliphatic KA dienols, the major degradation product under skin conditions, were more potent then KA itself. All dienols were found to be less toxic than KA at all tested concentrations. Additionally, the most lipophilic dienols were statistically more effective than KA at inhibiting melanin biosynthesis in cells. These KA-based polymer systems deliver KA analogues with improved efficacy and cytocompatible profiles, making them ideal candidates for sustained topical treatments in both medical and personal care products.


Assuntos
Materiais Biocompatíveis/química , Sistemas de Liberação de Medicamentos , Melaninas/biossíntese , Melanoma Experimental/tratamento farmacológico , Polímeros/administração & dosagem , Polímeros/química , Pironas/química , Animais , Sobrevivência Celular/efeitos dos fármacos , Melaninas/antagonistas & inibidores , Camundongos , Células NIH 3T3 , Polimerização , Células Tumorais Cultivadas
2.
Biomacromolecules ; 15(9): 3406-11, 2014 Sep 08.
Artigo em Inglês | MEDLINE | ID: mdl-25082798

RESUMO

The bioaccessibility of salicylic acid (SA) can be effectively modified by incorporating the pharmacological compound directly into polymers such as poly(anhydride-esters). After simulated digestion conditions, the bioaccessibility of SA was observed to be statistically different (p < 0.0001) in each sample: 55.5 ± 2.0% for free SA, 31.2 ± 2.4% the SA-diglycolic acid polymer precursor (SADG), and 21.2 ± 3.1% for SADG-P (polymer). The release rates followed a zero-order release rate that was dependent on several factors, including (1) solubilization rate, (2) macroscopic erosion of the powdered polymer, (3) hydrolytic cleavage of the anhydride bonds, and (4) subsequent hydrolysis of the polymer precursor (SADG) to SA and diglycolic acid.


Assuntos
Amiloide , Ouro/química , Nanopartículas Metálicas/química , Peptídeos , Poliésteres , Ácido Salicílico , Amiloide/síntese química , Amiloide/química , Disponibilidade Biológica , Peptídeos/síntese química , Peptídeos/química , Poliésteres/síntese química , Poliésteres/química , Poliésteres/farmacologia , Ácido Salicílico/química , Ácido Salicílico/farmacocinética
SELEÇÃO DE REFERÊNCIAS
DETALHE DA PESQUISA